This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Flameng, W. Articles by Brugmans, J. Search for Related Content PubMed PubMed Citation Articles by Flameng, W. Articles by Brugmans, J. Social Bookmarking                         What's this?

The Effect of Flunarizine Treatment on Human Red Blood Cells

K.U.L. University, Cardiovascular Department, Leuven, Belgium, Department of Cell Biology, Janssen Pharmaceutics, Beerse, Belgium

F. Verheyen

K.U.L. University, Cardiovascular Department, Leuven, Belgium, Department of Cell Biology, Janssen Pharmaceutics, Beerse, Belgium

M. Borgers

K.U.L. University, Cardiovascular Department, Leuven, Belgium, Department of Cell Biology, Janssen Pharmaceutics, Beerse, Belgium

F. De Clerck

K.U.L. University, Cardiovascular Department, Leuven, Belgium, Department of Cell Biology, Janssen Pharmaceutics, Beerse, Belgium

J. Brugmans

K.U.L. University, Cardiovascular Department, Leuven, Belgium, Department of Cell Biology, Janssen Pharmaceutics, Beerse, Belgium

In a first group of experiments, control and ischemic blood was sampled from healthy male volunteers before and 3 hours after the administration of a single 40-mg oral dose of flunarizine or placebo. The blood samples were stored for 24 hours at 0°C to induce partial transformation of discocytes into echi nocytes (crenation). The effect of the drug on the degree of crenation was evaluated by scanning electron microscopy. In control blood, flunarizine treat ment significantly suppressed the discocyte-echinocyte transformation. Similar results were obtained with ischemic blood, although individual variability was greater.

In a second group of experiments still in progress, control blood was taken from patients with intermittent claudication before and 24 hours after the first oral dose of flunarizine (4 x 20 mg) or placebo. The results again indicated that in patients flunarizine significantly reduced the echinocyte formation in stored blood samples.

Based on the results of earlier studies it is postulated that flunarizine exerts its effect at the plasma membrane of the erythrocyte by inhibiting excessive influx of extracellular Ca²⁺. This mechanism of action, by which the compound suppresses echinocyte formation, may be similar to that by which it reduces hyperviscosity and possibly improves red blood cell (RBC) deformability.

Angiology, Vol. 30, No. 8, 516-525 (1979)
DOI: 10.1177/000331977903000802


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?